599 related articles for article (PubMed ID: 15915004)
1. On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam.
Saletu A; Parapatics S; Saletu B; Anderer P; Prause W; Putz H; Adelbauer J; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(4):214-25. PubMed ID: 15915004
[TBL] [Abstract][Full Text] [Related]
2. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
3. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
4. Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo.
Saletu A; Parapatics S; Anderer P; Matejka M; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):163-74. PubMed ID: 19603241
[TBL] [Abstract][Full Text] [Related]
5. Effects of a mandibular repositioning appliance on sleep structure, morning behavior and clinical symptomatology in patients with snoring and sleep-disordered breathing.
Saletu A; Anderer P; Parapatics S; Matthai C; Matejka M; Saletu B
Neuropsychobiology; 2007; 55(3-4):184-93. PubMed ID: 17700043
[TBL] [Abstract][Full Text] [Related]
6. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
8. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
9. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Saletu M; Anderer P; Högl B; Saletu-Zyhlarz G; Kunz A; Poewe W; Saletu B
J Neural Transm (Vienna); 2003 Jun; 110(6):611-26. PubMed ID: 12768357
[TBL] [Abstract][Full Text] [Related]
10. Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam.
Saletu M; Anderer P; Saletu-Zyhlarz G; Prause W; Semler B; Zoghlami A; Gruber G; Hauer C; Saletu B
Eur Neuropsychopharmacol; 2001 Apr; 11(2):153-61. PubMed ID: 11313161
[TBL] [Abstract][Full Text] [Related]
11. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
12. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G
Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of periodic leg movements from arousals in restless legs syndrome.
Manconi M; Ferri R; Zucconi M; Bassetti CL; Fulda S; Aricò D; Ferini-Strambi L
Ann Neurol; 2012 Jun; 71(6):834-44. PubMed ID: 22718547
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
15. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
16. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality.
Donath F; Quispe S; Diefenbach K; Maurer A; Fietze I; Roots I
Pharmacopsychiatry; 2000 Mar; 33(2):47-53. PubMed ID: 10761819
[TBL] [Abstract][Full Text] [Related]
17. Effect of clonazepam and clonidine on primary sleep bruxism: a double-blind, crossover, placebo-controlled trial.
Sakai T; Kato T; Yoshizawa S; Suganuma T; Takaba M; Ono Y; Yoshizawa A; Yoshida Y; Kurihara T; Ishii M; Kawana F; Kiuchi Y; Baba K
J Sleep Res; 2017 Feb; 26(1):73-83. PubMed ID: 27485389
[TBL] [Abstract][Full Text] [Related]
18. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
19. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
20. First-night-effects on generalized anxiety disorder (GAD)-based insomnia: laboratory versus home sleep recordings.
Saletu B; Klösch G; Gruber G; Anderer P; Udomratn P; Frey R
Sleep; 1996 Nov; 19(9):691-7. PubMed ID: 9122554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
